{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:18:16Z","timestamp":1779196696685,"version":"3.51.4"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,30]]},"abstract":"<jats:p>Sodium-glucose co-transporter 2 inhibitors (SGLT2is) have consistently been shown to be beneficial in reducing the incidence rate of coronary heart disease (CHD) in diabetic patients. However, their specific pharmacological mechanisms are still unknown. Therefore, we intend to explore the mechanism of SGLT2is in patients with type 2 diabetes mellitus (T2DM) combined with CHD through a network pharmacological approach. Firstly, the Swiss Target Prediction and Drugbank databases were used to predict the targets of SGLT2is. The CHD dataset GSE113079 and T2DM dataset GSE118139 were downloaded from the gene expression omnibus database, and the differentially expressed genes (DEGs) were analyzed. Then, the predicted targets of SGLT2is intersected with the DEGs of the two diseases, and the results were used to construct the \u201cdrug-targeted-disease (D-T-D)\u201d and protein\u2013protein interaction networks. Gene Ontology functional analyses and Kyoto Encyclopedia of Genes and Genomes pathway were used for functional studies of target genes. Finally, molecular docking of SGLT2i with target proteins was performed using AutoDockTools software, and the docking results were verified by ELISA, RT-qPCR and western-blot experiments. Among the drug targets of SGLT2is and DEGs in T2DM and CHD, a total of 14 common gene targets exist, and these genes mainly affect the disease progression through the \u201cchemical carcinogenesis-reactive oxygen species\u201d,\u201capoptosis,\u201d and \u201cchemical carcinogenesis-receptor activation\u201d pathways. Through hub gene identification, we identified 11 hub genes from these 14 targets, of which epidermal growth factor receptor (EGFR) had the highest score. Molecular docking results showed that ertugliflozin had the strongest intermolecular binding to EGFR and that ertugliflozin improved the viability of high-glucose (HG)\/high-lipid combined hypoxia-reoxygenation-injured (HG\/HP\u2005+\u2005H\/R) cardiomyocytes and inhibited EGFR expression in cardiomyocytes. Based on network pharmacology and bioinformatics analysis, our study elucidated that EGFR is the hub gene for T2DM combined with CHD myocardial injury. Molecular docking and cell experiments further confirmed that SGLT2i-ERTU improves HG\/HP\u2005+\u2005H\/R myocardial cell injury by targeting EGFR. Our study deepened the pharmacological mechanism of SGLT2is in the treatment of T2DM combined with CHD and provided a new perspective and therapeutic basis for future experimental research and healthcare.<\/jats:p>","DOI":"10.1097\/md.0000000000047306","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T17:01:30Z","timestamp":1769965290000},"page":"e47306","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Bioinformatics study of the pharmacological mechanism of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes mellitus and coronary heart disease based on network pharmacology"],"prefix":"10.1097","volume":"105","author":[{"given":"Shuai","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, Peoples R China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingru","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, Peoples R China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Wu","sequence":"additional","affiliation":[{"name":"Zhumadian Central Hospital, Zhumadian, Henan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, Peoples R China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaguo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, Peoples R China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, Peoples R China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, Peoples R China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, Peoples R China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0263-9492","authenticated-orcid":false,"given":"Luqiao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, Peoples R China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260519","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.molcel.2013.08.017","article-title":"Circular intronic long noncoding RNAs.","volume":"51","author":"Zhang","year":"2013","journal-title":"Mol Cell"},{"key":"R2-20260519","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/jdi.13763","article-title":"Relationship between onset age of type 2 diabetes mellitus and vascular complications based on propensity score matching analysis.","volume":"13","author":"Huang","year":"2022","journal-title":"J Diabetes Investig"},{"key":"R3-20260519","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","article-title":"Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus \u2013 mechanisms, management, and clinical considerations.","volume":"133","author":"Low Wang","year":"2016","journal-title":"Circulation"},{"key":"R4-20260519","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.carrev.2021.08.003","article-title":"Diabetic patients who present with ST-elevation myocardial infarction.","volume":"38","author":"Megaly","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"key":"R5-20260519","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S2213-8587(19)30256-6","article-title":"SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis.","volume":"7","author":"Neuen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R6-20260519","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.3390\/ijerph16162965","article-title":"SGLT2 inhibitors: a review of their antidiabetic and cardioprotective effects.","volume":"16","author":"Tentolouris","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"R7-20260519","doi-asserted-by":"crossref","first-page":"1008922","DOI":"10.3389\/fcvm.2022.1008922","article-title":"Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: data from basic science and clinical trials.","volume":"9","author":"Scisciola","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R8-20260519","doi-asserted-by":"crossref","first-page":"e0143396","DOI":"10.1371\/journal.pone.0143396","article-title":"Amelioration of hyperglycemia with a sodium-glucose cotransporter 2 inhibitor prevents macrophage-driven atherosclerosis through macrophage foam cell formation suppression in type 1 and type 2 diabetic mice.","volume":"10","author":"Terasaki","year":"2015","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"R9-20260519","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.amjcard.2019.10.026","article-title":"Preventing and treating heart failure with sodium-glucose co-transporter 2 inhibitors.","volume":"124","author":"Vaduganathan","year":"2019","journal-title":"Am J Cardiol"},{"key":"R10-20260519","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3724\/SP.J.1009.2013.00110","article-title":"Traditional Chinese medicine network pharmacology: theory, methodology and application.","volume":"11","author":"Li","year":"2013","journal-title":"Chin J Nat Med"},{"key":"R11-20260519","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fphar.2019.00123","article-title":"Network pharmacology databases for traditional Chinese medicine: review and assessment.","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Pharmacol"},{"key":"R12-20260519","first-page":"377","article-title":"[Application of drug-target prediction technology in network pharmacology of traditional Chinese medicine].","volume":"41","author":"Wu","year":"2016","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"R13-20260519","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12967-023-04840-x","article-title":"Integrating network pharmacology and animal experimental validation to investigate the action mechanism of oleanolic acid in obesity.","volume":"22","author":"Liu","year":"2024","journal-title":"J Transl Med"},{"key":"R14-20260519","doi-asserted-by":"crossref","first-page":"e29558","DOI":"10.1016\/j.heliyon.2024.e29558","article-title":"Exploring the effective compounds and potential mechanisms of Shengxian Decoction against coronary heart disease by UPLC-Q-TOF\/MS and network pharmacology analysis.","volume":"10","author":"Zhou","year":"2024","journal-title":"Heliyon"},{"key":"R15-20260519","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.3390\/ijms20184331","article-title":"Molecular docking: shifting paradigms in drug discovery.","volume":"20","author":"Pinzi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R16-20260519","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies.","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules (Basel, Switzerland)"},{"key":"R17-20260519","doi-asserted-by":"crossref","first-page":"105389","DOI":"10.1016\/j.compbiomed.2022.105389","article-title":"Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu decoction against sepsis.","volume":"144","author":"Li","year":"2022","journal-title":"Comput Biol Med"},{"key":"R18-20260519","doi-asserted-by":"crossref","first-page":"8895950","DOI":"10.1155\/2022\/8895950","article-title":"Using network pharmacology to explore the mechanism of panax notoginseng in the treatment of myocardial fibrosis.","volume":"2022","author":"Han","year":"2022","journal-title":"J Diabetes Res"},{"key":"R19-20260519","doi-asserted-by":"crossref","first-page":"W623","DOI":"10.1093\/nar\/gkp456","article-title":"PubChem: a public information system for analyzing bioactivities of small molecules.","volume":"37","author":"Wang","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"R20-20260519","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1758-2946-3-32","article-title":"PubChem3D: a new resource for scientists.","volume":"3","author":"Bolton","year":"2011","journal-title":"J Cheminf"},{"key":"R21-20260519","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules.","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"R22-20260519","doi-asserted-by":"crossref","first-page":"D901","DOI":"10.1093\/nar\/gkm958","article-title":"DrugBank: a knowledgebase for drugs, drug actions and drug targets.","volume":"36","author":"Wishart","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"R23-20260519","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","article-title":"The gene expression omnibus database.","volume":"1418","author":"Clough","year":"2016","journal-title":"Methods Mol Biol"},{"key":"R24-20260519","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets--update.","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"R25-20260519","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks.","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"R26-20260519","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"R27-20260519","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"Suppl 4","key":"R28-20260519","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome.","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst Biol"},{"key":"R29-20260519","first-page":"440","article-title":"Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular outcomes in elderly patients with comorbid coronary heart disease and diabetes mellitus.","volume":"18","author":"Xu","year":"2021","journal-title":"J Geriatr Cardiol"},{"key":"R30-20260519","doi-asserted-by":"crossref","first-page":"e1004201","DOI":"10.1371\/journal.pgen.1004201","article-title":"Plasma cholesterol-induced lesion networks activated before regression of early, mature, and advanced atherosclerosis.","volume":"10","author":"Bj\u00f6rkegren","year":"2014","journal-title":"PLoS Genet"},{"key":"R31-20260519","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0002-9343(99)00153-9","article-title":"Cellular adhesion molecules and atherogenesis.","volume":"107","author":"Price","year":"1999","journal-title":"Am J Med"},{"key":"R32-20260519","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1289\/ehp.1307379","article-title":"SRC-mediated EGF receptor activation regulates ozone-induced interleukin 8 expression in human bronchial epithelial cells.","volume":"123","author":"Wu","year":"2015","journal-title":"Environ Health Perspect"},{"key":"R33-20260519","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3390\/biomedicines9040328","article-title":"Endothelial barrier function and leukocyte transmigration in atherosclerosis.","volume":"9","author":"Sluiter","year":"2021","journal-title":"Biomedicines"},{"key":"R34-20260519","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrm2239","article-title":"Self-eating and self-killing: crosstalk between autophagy and apoptosis.","volume":"8","author":"Maiuri","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R35-20260519","doi-asserted-by":"crossref","first-page":"6984","DOI":"10.12659\/MSM.910763","article-title":"Relationship of autophagy and apoptosis with total occlusion of coronary arteries.","volume":"24","author":"Kaplan","year":"2018","journal-title":"Med Sci Monit"},{"key":"R36-20260519","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0735-1097(02)02959-5","article-title":"Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure.","volume":"41","author":"Abbate","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R37-20260519","first-page":"247","article-title":"Apoptosis in recent myocardial infarction.","volume":"151","author":"Abbate","year":"2000","journal-title":"Clin Ter"},{"key":"R38-20260519","doi-asserted-by":"crossref","first-page":"e55477","DOI":"10.1371\/journal.pone.0055477","article-title":"Soluble TNF receptors are associated with infarct size and ventricular dysfunction in ST-elevation myocardial infarction.","volume":"8","author":"Nilsson","year":"2013","journal-title":"PLoS One"},{"key":"R39-20260519","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drudis.2021.09.007","article-title":"Machine-learning methods for ligand-protein molecular docking.","volume":"27","author":"Crampon","year":"2022","journal-title":"Drug Discov Today"},{"key":"R40-20260519","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1039\/D4OB00301B","article-title":"Intermolecular hydrogen bonding behavior of amino acid radical cations.","volume":"22","author":"Moppel","year":"2024","journal-title":"Organ Biomol Chem"},{"key":"R41-20260519","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1172\/JCI82826","article-title":"PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response.","volume":"125","author":"Liao","year":"2015","journal-title":"J Clin Invest"},{"key":"R42-20260519","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000357004","article-title":"Remodeling and fibrosis in chronic eosinophil inflammation.","volume":"32","author":"Aceves","year":"2014","journal-title":"Dig Dis"},{"key":"R43-20260519","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2337\/db13-1279","article-title":"Epidermal growth factor receptor inhibition slows progression of diabetic nephropathy in association with a decrease in endoplasmic reticulum stress and an increase in autophagy.","volume":"63","author":"Zhang","year":"2014","journal-title":"Diabetes"},{"key":"R44-20260519","doi-asserted-by":"crossref","first-page":"878","DOI":"10.7150\/ijms.71780","article-title":"Nephronectin promotes cardiac repair post myocardial infarction via activating EGFR\/JAK2\/STAT3 pathway.","volume":"19","author":"Zhang","year":"2022","journal-title":"Int J Med Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047306","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:04:11Z","timestamp":1779195851000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047306","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"2024-12-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}